Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 4/2011

01-04-2011 | Bone and Soft Tissue Sarcomas

Surgical Approach and Oncologic Outcomes Following Multidisciplinary Management of Retrorectal Sarcomas

Authors: Eric J. Dozois, MD, David J. Jacofsky, MD, Brian J. Billings, MD, Antonio Privitera, MD, PhD, Robert R. Cima, MD, Peter S. Rose, MD, Franklin H. Sim, MD, Scott H. Okuno, MD, Michael G. Haddock, MD, William S. Harmsen, MS, Carrie Y. Inwards, MD, David W. Larson, MD

Published in: Annals of Surgical Oncology | Issue 4/2011

Login to get access

Abstract

Background

Retrorectal sarcomas are rare, and limited data are available on oncologic outcomes following surgery. Our aim was to evaluate outcomes in this patient population at our institution.

Materials and Methods

All patients who underwent surgical resection of a malignant retrorectal/presacral sarcoma between 1985 and 2005 were identified. Data analyzed included demographics, histopathologic diagnosis, surgical morbidity and mortality, use of adjuvant therapy, local and distant recurrence, and survival.

Results

A total of 37 patients were identified (20 males) with a median age of 49 years (range, 22–81 years). The most common histopathologic diagnosis was malignant peripheral nerve sheath tumor (n = 8). Also, 22 tumors were high grade and 15 were low grade. Surgical margin status was R0 in 31 patients and R1 in 6. Adjuvant therapy was given to 26 patients. Postoperative morbidity and mortality was 57% and 3%, respectively. Median length of follow-up in 16 patients alive at last contact was 4.7 years. The 5-year survival free of local (LDFS), distant (DDFS), and local or distant recurrence (DFS) was 51, 58, and 39%, respectively. Patient survival at 2, 5, and 10 years was 75, 55, and 47%, respectively. Disease-free survival was not significantly associated with gender (P = .16), primary vs secondary (P = .94), R0 vs R1 resection (P = .26), low vs high tumor grade (P = .17), or the use of surgery with or without adjuvant therapy (P = .33).

Conclusions

Retrorectal sarcomas are often high grade and locally advanced. Most tumors are resectable with free margins, and long-term survival may be possible in up to one-half of patients following an aggressive surgical approach.
Literature
1.
Cody HS 3rd, Marcove RC, Quan SH. Malignant retrorectal tumors: 28 years’ experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum. 1981;24:501–6.PubMedCrossRef
2.
Gray SW, Singhabhandhu B, Smith RA, Skandalakis JE. Sacrococcygeal chordoma: report of a case and review of the literature. Surgery. 1975;78:573–82.PubMed
3.
Jao SW, Beart RW Jr, Spencer RJ, Reiman HM, Ilstrup DM. Retrorectal tumors: Mayo Clinic experience, 1960–1979. Dis Colon Rectum. 1985;28:644–52.PubMedCrossRef
4.
Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J Bone Joint Surg. 2005;87:2211–6.PubMedCrossRef
5.
Jackman RJ, Clark PL III, Smith ND. Retrorectal tumors. JAMA. 1951;145:956–62.
6.
7.
Wang JY, Hsu CH, Changchien CR, Chen JS, Hsu KC, You YT, et al. Presacral tumor: a review of forty-five cases. Am Surg. 1995;61:310–5.PubMed
8.
Herr HW. Sarcomas of the urinary tract. In: de Kernion JB, Paulson DF, editors. Genitourinary Cancer Management. Philadelphia, PA: Lea & Febiger; 1987. p. 259–70.
9.
Russo P, Brady MS, Conlon K, Hajdu SI, Fair WR, Herr HW, et al. Adult urological sarcoma. J Urol. 1992;47:1032–7.
10.
Mackenzie S, Reid R, Barrett A, O’Dwyer PJ. Management of soft tissue sarcomas of the abdomen and pelvis. Colorectal Dis. 2003;5:129–32.PubMedCrossRef
11.
Keyzer-Dekker CM, Houtkamp RG, Peterse JL, van Coevorden F. Adult pelvic sarcomas: a heterogeneous collection of sarcomas. Sarcoma. 2004;8:19–24.PubMedCrossRef
12.
Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma. Analysis of 500 patients treated and followed at a singe institution. Ann Surg. 1998;228:355–65.PubMedCrossRef
13.
Karakousis CP, Kontzoglou K, Driscoll DL. Resectability of retroperitoneal sarcomas; a matter of surgical technique? Eur J Surg Oncol. 1995;21:617–22.PubMedCrossRef
14.
Zhang G, Chen KK, Manivel C, Fraley EE. Sarcomas of the retroperitoneum and genitourinary tract. J Urol. 1989;141:1107–10.PubMed
15.
Raut CP, Pisters PW. Retroperitoneal sarcomas: combined-modality treatment approaches. J Surg Oncol. 2006;94:81–7.PubMedCrossRef
16.
Yang J, Chang A, Baker A, Sindelar WF, Danforth DN, Topalian SL, et al. Randomized prospective study of benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203.PubMed
17.
Feng M, Murphy J, Griffith KA. Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma. Int J Radiat Oncol Biol Phys. 2007;69:103–10.PubMedCrossRef
18.
Rosenberg S, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluation of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant therapy. Ann Surg. 1982;196:305–15.PubMedCrossRef
19.
Tierney J, Stewart L, Parmar M, et al. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adult: meta-analysis of individual data. Lancet. 1997;350:1647–54.CrossRef
20.
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. p. 291.
Metadata
Title
Surgical Approach and Oncologic Outcomes Following Multidisciplinary Management of Retrorectal Sarcomas
Authors
Eric J. Dozois, MD
David J. Jacofsky, MD
Brian J. Billings, MD
Antonio Privitera, MD, PhD
Robert R. Cima, MD
Peter S. Rose, MD
Franklin H. Sim, MD
Scott H. Okuno, MD
Michael G. Haddock, MD
William S. Harmsen, MS
Carrie Y. Inwards, MD
David W. Larson, MD
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 4/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1445-x

Other articles of this Issue 4/2011

Annals of Surgical Oncology 4/2011 Go to the issue

Breast Oncology

Areola and Nipple-Areola-Sparing Mastectomy for Breast Cancer Treatment and Risk Reduction: Report of an Initial Experience in a Community Hospital Setting

Hepatobiliary Tumors

Effect on Outcome of Recurrence Patterns After Hepatectomy for Colorectal Metastases

Melanomas

Initial Experience with Videoscopic Inguinal Lymphadenectomy

Breast Oncology

Alternative Therapy for Breast Cancer: Outcomes, Obstacles and Opportunities

Breast Oncology

Alternative Therapy Used as Primary Treatment for Breast Cancer Negatively Impacts Outcomes

Breast Oncology

Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer